Temat: "Circulating tumor cell" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Prognostic value of circulating tumor cells associated with white blood cells in solid cancer: a systematic review and meta-analysis of 1471 patients with solid tumors.
Autorzy:: Ju M; Department of Surgical Oncology and General Surgery, Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, Heping District, The First Affiliated Hospital of China Medical University, 155 North Nanjing Street, Shenyang City, 110001, China.
Gao Z; Department of Surgical Oncology and General Surgery, Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, Heping District, The First Affiliated Hospital of China Medical University, 155 North Nanjing Street, Shenyang City, 110001, China.
Gu G; Department of Surgical Oncology and General Surgery, Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, Heping District, The First Affiliated Hospital of China Medical University, 155 North Nanjing Street, Shenyang City, 110001, China.
Huang H; VIP International Department, Heping District, The First Affiliated Hospital of China Medical University, 155 North Nanjing Street, Shenyang City, 110001, China.
Sun A; VIP International Department, Heping District, The First Affiliated Hospital of China Medical University, 155 North Nanjing Street, Shenyang City, 110001, China.
Zheng C; Department of Anesthesiology, Heping District, The First Affiliated Hospital of China Medical University, 155 North Nanjing Street, Shenyang City, 110001, China.
Li H; Department of Ultrasound, Heping District, The First Affiliated Hospital of China Medical University, 155 North Nanjing Street, Shenyang City, 110001, China.
Zhang Y; Department of Surgical Oncology and General Surgery, Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, Heping District, The First Affiliated Hospital of China Medical University, 155 North Nanjing Street, Shenyang City, 110001, China.
Li K; Department of Surgical Oncology and General Surgery, Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, Heping District, The First Affiliated Hospital of China Medical University, 155 North Nanjing Street, Shenyang City, 110001, China. cmu_.; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2023 Dec 12; Vol. 23 (1), pp. 1224. Date of Electronic Publication: 2023 Dec 12.
Typ publikacji:: Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:: Neoplastic Cells, Circulating*/pathology
Liver Neoplasms*
Humans ; Prognosis ; Disease-Free Survival ; Progression-Free Survival

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Liquid-based biomarkers in breast cancer: looking beyond the blood.
Autorzy:: Shuai Y; Department of VIP Medical Services, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Ma Z; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Endoscopy, Peking University Cancer Hospital & Institute, Beijing, 100142, China.
Ju J; Department of VIP Medical Services, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Wei T; Department of VIP Medical Services, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Gao S; Department of VIP Medical Services, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Kang Y; Department of VIP Medical Services, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Yang Z; Department of VIP Medical Services, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Wang X; Department of VIP Medical Services, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Yue J; Department of VIP Medical Services, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Yuan P; Department of VIP Medical Services, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China. .; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2023 Nov 13; Vol. 21 (1), pp. 809. Date of Electronic Publication: 2023 Nov 13.
Typ publikacji:: Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms*/diagnosis
Neoplastic Cells, Circulating*/pathology
Humans ; Female ; Biomarkers, Tumor/genetics ; Liquid Biopsy ; DNA, Neoplasm/genetics ; RNA, Neoplasm

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Personalized cancer avatars for patients with thymic malignancies: A pilot study with circulating tumor cell-derived organoids.
Autorzy:: Wu YH; Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan.; School of Medicine, National Yang-Ming Chiao-Tung University, Taipei, Taiwan.; Department of Biomedical Imaging and Radiological Sciences, National Yang-Ming Chiao-Tung University, Taipei, Taiwan.
Chao HS; School of Medicine, National Yang-Ming Chiao-Tung University, Taipei, Taiwan.; Department of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Chiang CL; School of Medicine, National Yang-Ming Chiao-Tung University, Taipei, Taiwan.; Department of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Luo YH; School of Medicine, National Yang-Ming Chiao-Tung University, Taipei, Taiwan.; Department of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Chiu CH; Department of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Taipei Cancer Center and Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan.
Yen SH; Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan.; Department of Biomedical Imaging and Radiological Sciences, National Yang-Ming Chiao-Tung University, Taipei, Taiwan.; Department of Radiation Oncology, Taipei Municipal Wan-Fang Hospital, Taipei, Taiwan.
Liu CY; Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan.; School of Medicine, National Yang-Ming Chiao-Tung University, Taipei, Taiwan.
Chiou JF; Department of Radiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.; Department of Radiation Oncology, Taipei Medical University, Taipei, Taiwan.; TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei, Taiwan.
Burnouf T; Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan.; International Ph.D. Program for Cell Therapy and Regenerative Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Chen YJ; TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei, Taiwan.; Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan.; International Ph.D. Program for Cell Therapy and Regenerative Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.; Department of Radiation Oncology, Taipei Medical University Hospital, Taipei, Taiwan.; Department of Medical Research, Taipei Medical University, Taipei, Taiwan.
Wang PY; Oujiang Laboratory, Wenzhou, China.; Key Laboratory of Alzheimer's Disease of Zhejiang Province, Institute of Aging, Wenzhou Medical University, Wenzhou, China.
Chao TY; Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.; Division of Hematology/Oncology, Department of Medicine, Tri-service General Hospital, National Defense Medical Center, Taipei, Taiwan.; Division of Hematology and Oncology, Department of Internal Medicine, Taipei Medical University-Shuang Ho Hospital, New Taipei City, Taiwan.; Taipei Cancer Center, Taipei Medical University, Taipei, Taiwan.
Hsu SM; Department of Biomedical Imaging and Radiological Sciences, National Yang-Ming Chiao-Tung University, Taipei, Taiwan.
Lu LS; TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei, Taiwan.; Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan.; International Ph.D. Program for Cell Therapy and Regenerative Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.; Department of Radiation Oncology, Taipei Medical University Hospital, Taipei, Taiwan.; Pokaż więcej
Źródło:: Thoracic cancer [Thorac Cancer] 2023 Sep; Vol. 14 (25), pp. 2591-2600. Date of Electronic Publication: 2023 Jul 20.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Neoplastic Cells, Circulating*/pathology
Thymus Neoplasms*/pathology
Pancreatic Neoplasms*/pathology
Humans ; Pilot Projects ; Organoids/pathology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Raman Spectroscopy Combined with Malaria Protein for Early Capture and Recognition of Broad-Spectrum Circulating Tumor Cells.
Autorzy:: Liu X; Key Laboratory of Marine Drugs, Ministry of Education, Qingdao Marine Biomedical Research Institute, Ocean University of China, Qingdao 266071, China.; Innovation Platform of Marine Drug Screening & Evaluation, Qingdao Marine Science and Technology Center, Qingdao 266100, China.
Zhang Y; Key Laboratory of Marine Drugs, Ministry of Education, Qingdao Marine Biomedical Research Institute, Ocean University of China, Qingdao 266071, China.; Innovation Platform of Marine Drug Screening & Evaluation, Qingdao Marine Science and Technology Center, Qingdao 266100, China.
Li X; Single-Cell Center, CAS Key Laboratory of Biofuels, Shandong Key Laboratory of Energy Genetics and Shandong Energy Institute, Qingdao Institute of Bioenergy and Bioprocess Technology, Chinese Academy of Sciences, Qingdao 266071, China.; University of Chinese Academy of Sciences, Beijing 100000, China.
Xu J; Single-Cell Center, CAS Key Laboratory of Biofuels, Shandong Key Laboratory of Energy Genetics and Shandong Energy Institute, Qingdao Institute of Bioenergy and Bioprocess Technology, Chinese Academy of Sciences, Qingdao 266071, China.; University of Chinese Academy of Sciences, Beijing 100000, China.
Zhao C; Key Laboratory of Marine Drugs, Ministry of Education, Qingdao Marine Biomedical Research Institute, Ocean University of China, Qingdao 266071, China.; Innovation Platform of Marine Drug Screening & Evaluation, Qingdao Marine Science and Technology Center, Qingdao 266100, China.
Yang J; Key Laboratory of Marine Drugs, Ministry of Education, Qingdao Marine Biomedical Research Institute, Ocean University of China, Qingdao 266071, China.; Innovation Platform of Marine Drug Screening & Evaluation, Qingdao Marine Science and Technology Center, Qingdao 266100, China.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Jul 28; Vol. 24 (15). Date of Electronic Publication: 2023 Jul 28.
Typ publikacji:: Journal Article
MeSH Terms:: Neoplastic Cells, Circulating*/pathology
Humans ; Spectrum Analysis, Raman ; Antibodies/chemistry ; A549 Cells ; Recombinant Proteins ; Cell Line, Tumor ; Biomarkers, Tumor

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Clinical Validation of a Size-Based Microfluidic Device for Circulating Tumor Cell Isolation and Analysis in Renal Cell Carcinoma.
Autorzy:: Leitão TP; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-028 Lisboa, Portugal.; Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-028 Lisboa, Portugal.; Urology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Av. Prof. Egas Moniz, 1649-028 Lisboa, Portugal.
Corredeira P; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-028 Lisboa, Portugal.
Kucharczak S; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-028 Lisboa, Portugal.; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Erling Skjalgsons gate 1, 7491 Trondheim, Norway.
Rodrigues M; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-028 Lisboa, Portugal.; Biological Engineering Department, Instituto Superior Técnico, Av. Rovisco Pais 1, 1049-001 Lisboa, Portugal.
Piairo P; International Iberian Nanotechnology Laboratory, Avenida Mestre José Veiga s/n, 4715-330 Braga, Portugal.; RUBYnanomed Lda, Praça Conde de Agrolongo 123, 4700-312 Braga, Portugal.
Rodrigues C; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-028 Lisboa, Portugal.; International Iberian Nanotechnology Laboratory, Avenida Mestre José Veiga s/n, 4715-330 Braga, Portugal.
Alves P; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-028 Lisboa, Portugal.
Cavaco AM; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-028 Lisboa, Portugal.
Miranda M; Urology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Av. Prof. Egas Moniz, 1649-028 Lisboa, Portugal.
Antunes M; CEAUL-Centro de Estatística e Aplicações, Faculdade de Ciências, Universidade de Lisboa, 1749-016 Lisboa, Portugal.
Ferreira J; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-028 Lisboa, Portugal.
Palma Reis J; Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-028 Lisboa, Portugal.; Urology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Av. Prof. Egas Moniz, 1649-028 Lisboa, Portugal.
Lopes T; Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-028 Lisboa, Portugal.
Diéguez L; International Iberian Nanotechnology Laboratory, Avenida Mestre José Veiga s/n, 4715-330 Braga, Portugal.; RUBYnanomed Lda, Praça Conde de Agrolongo 123, 4700-312 Braga, Portugal.
Costa L; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-028 Lisboa, Portugal.; Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-028 Lisboa, Portugal.; Oncology Division, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Av. Prof. Egas Moniz, 1649-028 Lisboa, Portugal.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 May 07; Vol. 24 (9). Date of Electronic Publication: 2023 May 07.
Typ publikacji:: Journal Article
MeSH Terms:: Neoplastic Cells, Circulating*/pathology
Carcinoma, Renal Cell*
Kidney Neoplasms*/pathology
Humans ; Microfluidics ; Cell Line ; Biomarkers, Tumor/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Prognostic Role of Circulating Tumor Cell Trajectories in Metastatic Colorectal Cancer.
Autorzy:: Magri V; Department of Pathology, Oncology and Radiology, Sapienza University of Rome, 00161 Rome, Italy.
Marino L; Department of Mechanical and Aerospace Engineering, Sapienza University of Rome, 00184 Rome, Italy.
Nicolazzo C; Department of Molecular Medicine, Sapienza University of Rome, 00161 Rome, Italy.
Gradilone A; Department of Molecular Medicine, Sapienza University of Rome, 00161 Rome, Italy.
De Renzi G; Department of Molecular Medicine, Sapienza University of Rome, 00161 Rome, Italy.
De Meo M; Department of Molecular Medicine, Sapienza University of Rome, 00161 Rome, Italy.
Gandini O; Department of Molecular Medicine, Sapienza University of Rome, 00161 Rome, Italy.
Sabatini A; Department of Pathology, Oncology and Radiology, Sapienza University of Rome, 00161 Rome, Italy.
Santini D; Department of Pathology, Oncology and Radiology, Sapienza University of Rome, 00161 Rome, Italy.
Cortesi E; Department of Pathology, Oncology and Radiology, Sapienza University of Rome, 00161 Rome, Italy.
Gazzaniga P; Department of Molecular Medicine, Sapienza University of Rome, 00161 Rome, Italy.; Pokaż więcej
Źródło:: Cells [Cells] 2023 Apr 16; Vol. 12 (8). Date of Electronic Publication: 2023 Apr 16.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Neoplastic Cells, Circulating*/pathology
Colorectal Neoplasms*/pathology
Humans ; Prognosis ; Biomarkers, Tumor ; Disease-Free Survival

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Quantification and Characterization of CTCs and Clusters in Pancreatic Cancer by Means of the Hough Transform Algorithm.
Autorzy:: Calero-Castro FJ; Department of General Surgery, Hospital University Virgen del Rocío/CSIC/University of Seville/IBiS, 41013 Seville, Spain.; Oncology Surgery, Cell Therapy, and Organ Transplantation Group, Institute of Biomedicine of Seville (IBiS), Virgen del Rocio University Hospital, University of Seville, 41013 Seville, Spain.
Pereira S; Department of General Surgery, Hospital University Virgen del Rocío/CSIC/University of Seville/IBiS, 41013 Seville, Spain.; Oncology Surgery, Cell Therapy, and Organ Transplantation Group, Institute of Biomedicine of Seville (IBiS), Virgen del Rocio University Hospital, University of Seville, 41013 Seville, Spain.
Laga I; Department of General Surgery, Hospital University Virgen del Rocío/CSIC/University of Seville/IBiS, 41013 Seville, Spain.; Oncology Surgery, Cell Therapy, and Organ Transplantation Group, Institute of Biomedicine of Seville (IBiS), Virgen del Rocio University Hospital, University of Seville, 41013 Seville, Spain.
Villanueva P; Department of General Surgery, Hospital University Virgen del Rocío/CSIC/University of Seville/IBiS, 41013 Seville, Spain.; Oncology Surgery, Cell Therapy, and Organ Transplantation Group, Institute of Biomedicine of Seville (IBiS), Virgen del Rocio University Hospital, University of Seville, 41013 Seville, Spain.
Suárez-Artacho G; Department of General Surgery, Hospital University Virgen del Rocío/CSIC/University of Seville/IBiS, 41013 Seville, Spain.; Oncology Surgery, Cell Therapy, and Organ Transplantation Group, Institute of Biomedicine of Seville (IBiS), Virgen del Rocio University Hospital, University of Seville, 41013 Seville, Spain.
Cepeda-Franco C; Department of General Surgery, Hospital University Virgen del Rocío/CSIC/University of Seville/IBiS, 41013 Seville, Spain.; Oncology Surgery, Cell Therapy, and Organ Transplantation Group, Institute of Biomedicine of Seville (IBiS), Virgen del Rocio University Hospital, University of Seville, 41013 Seville, Spain.
de la Cruz-Ojeda P; Oncology Surgery, Cell Therapy, and Organ Transplantation Group, Institute of Biomedicine of Seville (IBiS), Virgen del Rocio University Hospital, University of Seville, 41013 Seville, Spain.
Navarro-Villarán E; Oncology Surgery, Cell Therapy, and Organ Transplantation Group, Institute of Biomedicine of Seville (IBiS), Virgen del Rocio University Hospital, University of Seville, 41013 Seville, Spain.
Dios-Barbeito S; Department of General Surgery, Hospital University Virgen del Rocío/CSIC/University of Seville/IBiS, 41013 Seville, Spain.; Oncology Surgery, Cell Therapy, and Organ Transplantation Group, Institute of Biomedicine of Seville (IBiS), Virgen del Rocio University Hospital, University of Seville, 41013 Seville, Spain.
Serrano MJ; Department of Liquid Biopsy, Genyo, 18016 Granada, Spain.
Fresno C; Health and Sciences Research Center, Health and Sciences Faculty, Anahuac University, Huixquilucan 52760, Mexico.
Padillo-Ruiz J; Department of General Surgery, Hospital University Virgen del Rocío/CSIC/University of Seville/IBiS, 41013 Seville, Spain.; Oncology Surgery, Cell Therapy, and Organ Transplantation Group, Institute of Biomedicine of Seville (IBiS), Virgen del Rocio University Hospital, University of Seville, 41013 Seville, Spain.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Feb 21; Vol. 24 (5). Date of Electronic Publication: 2023 Feb 21.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Pancreatic Ductal*/pathology
Neoplastic Cells, Circulating*/pathology
Pancreatic Neoplasms*/pathology
Humans ; Biomarkers, Tumor/metabolism ; Algorithms ; Pancreatic Neoplasms

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Circulating tumor cells in neuroblastoma: Current status and future perspectives.
Autorzy:: Yang R; Department of Pediatric Surgery, Children's Hospital of Fudan University, Shanghai, China.
Zheng S; Department of Pediatric Surgery, Children's Hospital of Fudan University, Shanghai, China.
Dong R; Department of Pediatric Surgery, Children's Hospital of Fudan University, Shanghai, China.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2023 Jan; Vol. 12 (1), pp. 7-19. Date of Electronic Publication: 2022 May 27.
Typ publikacji:: Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:: Neoplastic Cells, Circulating*/pathology
Neuroblastoma*/genetics
Circulating Tumor DNA*
Child ; Humans ; Prospective Studies ; Prognosis ; Biomarkers, Tumor/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Potential values of circulating tumor cell for detection of recurrence in patients of thyroid cancer: a diagnostic meta-analysis.
Autorzy:: Liang MX; Department of General Surgery, the First Affiliated Hospital of Nanjing Medical University, 210029, Nanjing, P.R. China.
Fei YJ; Department of General Surgery, the First Affiliated Hospital of Nanjing Medical University, 210029, Nanjing, P.R. China.
Yang K; School of Clinical Medicine, Xuzhou Medical University, 221000, Xuzhou, P.R. China.
Tang WJ; Department of General Surgery, the First Affiliated Hospital of Nanjing Medical University, 210029, Nanjing, P.R. China.
Cao XH; School of Clinical Medicine, Xuzhou Medical University, 221000, Xuzhou, P.R. China.
Tang JH; Department of General Surgery, the First Affiliated Hospital of Nanjing Medical University, 210029, Nanjing, P.R. China. .; School of Clinical Medicine, Xuzhou Medical University, 221000, Xuzhou, P.R. China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2022 Sep 05; Vol. 22 (1), pp. 954. Date of Electronic Publication: 2022 Sep 05.
Typ publikacji:: Journal Article; Meta-Analysis
MeSH Terms:: Neoplastic Cells, Circulating*
Thyroid Neoplasms*/diagnosis
Biomarkers ; Epithelial Cell Adhesion Molecule ; Humans ; Neoplasm Recurrence, Local/diagnosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Single-Circulating Tumor Cell Whole Genome Amplification to Unravel Cancer Heterogeneity and Actionable Biomarkers.
Autorzy:: Khan T; School of Medicine, Western Sydney University, Campbelltown, NSW 2560, Australia.; Medical Oncology, Ingham Institute of Applied Medical Research, Liverpool, NSW 2170, Australia.; Centre of Circulating Tumor Cells Diagnostics & Research, Ingham Institute of Applied Medical Research, Liverpool, NSW 2170, Australia.
Becker TM; School of Medicine, Western Sydney University, Campbelltown, NSW 2560, Australia.; Medical Oncology, Ingham Institute of Applied Medical Research, Liverpool, NSW 2170, Australia.; Centre of Circulating Tumor Cells Diagnostics & Research, Ingham Institute of Applied Medical Research, Liverpool, NSW 2170, Australia.; South West Sydney Clinical School, University of New South Wales, Liverpool, NSW 2170, Australia.
Po JW; Centre of Circulating Tumor Cells Diagnostics & Research, Ingham Institute of Applied Medical Research, Liverpool, NSW 2170, Australia.; Surgical Innovations Unit, Westmead Hospital, Westmead, NSW 2145, Australia.
Chua W; School of Medicine, Western Sydney University, Campbelltown, NSW 2560, Australia.; Medical Oncology, Liverpool Hospital, Liverpool, NSW 2170, Australia.
Ma Y; School of Medicine, Western Sydney University, Campbelltown, NSW 2560, Australia.; Medical Oncology, Ingham Institute of Applied Medical Research, Liverpool, NSW 2170, Australia.; Centre of Circulating Tumor Cells Diagnostics & Research, Ingham Institute of Applied Medical Research, Liverpool, NSW 2170, Australia.; South West Sydney Clinical School, University of New South Wales, Liverpool, NSW 2170, Australia.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2022 Jul 29; Vol. 23 (15). Date of Electronic Publication: 2022 Jul 29.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Neoplastic Cells, Circulating*/pathology
Biomarkers, Tumor/genetics ; Humans ; Liquid Biopsy ; Prospective Studies ; Single-Cell Analysis/methods

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Dynamic detection of HER2 of circulating tumor cells in patients with gastric carcinoma and its clinical application.
Autorzy:: Zhao H; Department of General Surgery, Zhabei District Central Hospital of Shanghai, Shanghai 200070, P.R. China.
Huang C; Department of Anesthesia, Zhabei District Central Hospital of Shanghai, Shanghai 200070, P.R. China.
Lin M; Department of Anesthesia, The People's Hospital of Suzhou New District, Suzhou, Jiangsu 215163, P.R. China.
Zhou M; Department of General Surgery, Zhabei District Central Hospital of Shanghai, Shanghai 200070, P.R. China.
Huang C; Department of General Surgery, Huadong Hospital Affiliated to Fudan University, Shanghai 200040, P.R. China.; Pokaż więcej
Źródło:: Molecular medicine reports [Mol Med Rep] 2022 May; Vol. 25 (5). Date of Electronic Publication: 2022 Mar 29.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*
Carcinoma*
Neoplastic Cells, Circulating*/metabolism
Biomarkers, Tumor/genetics ; Female ; Humans ; In Situ Hybridization, Fluorescence ; Receptor, ErbB-2/genetics ; Receptor, ErbB-2/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Liquid Biopsy in Metastatic Breast Cancer: Current Role of Circulating Tumor Cells and Circulating Tumor DNA.
Autorzy:: Banys-Paluchowski M; Department of Obstetrics and Gynecology, University Hospital of Schleswig Holstein, Campus Lübeck, Lübeck, Germany, .; Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany, .
Fehm TN; Department of Gynecology and Obstetrics, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
Grimm-Glang D; Department of Obstetrics and Gynecology, University Hospital of Schleswig Holstein, Campus Lübeck, Lübeck, Germany.
Rody A; Department of Obstetrics and Gynecology, University Hospital of Schleswig Holstein, Campus Lübeck, Lübeck, Germany.
Krawczyk N; Department of Gynecology and Obstetrics, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.; Pokaż więcej
Źródło:: Oncology research and treatment [Oncol Res Treat] 2022; Vol. 45 (1-2), pp. 4-11. Date of Electronic Publication: 2021 Oct 29.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Breast Neoplasms*/drug therapy
Circulating Tumor DNA*
Neoplastic Cells, Circulating*
Biomarkers, Tumor ; Female ; Humans ; Liquid Biopsy ; Prognosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Circulating tumor cells in patients undergoing androgen deprivation therapy with versus without cryosurgery for metastatic prostate cancer: a retrospective analysis.
Autorzy:: Sheng M; Department of Urology, Zhujiang Hospital, Southern Medical University, No. 253, Industrial Rd., Guangzhou, Guangdong Province, 510282, People's Republic of China.; Department of Urology, Mindong Hospital affiliated to Fujian Medical University, Fuan, Fujian Province, 355000, People's Republic of China.
Guo S; Department of Urology, Mindong Hospital affiliated to Fujian Medical University, Fuan, Fujian Province, 355000, People's Republic of China.
Liu C; Department of Urology, Zhujiang Hospital, Southern Medical University, No. 253, Industrial Rd., Guangzhou, Guangdong Province, 510282, People's Republic of China. .; Pokaż więcej
Źródło:: World journal of surgical oncology [World J Surg Oncol] 2021 Dec 13; Vol. 19 (1), pp. 345. Date of Electronic Publication: 2021 Dec 13.
Typ publikacji:: Journal Article
MeSH Terms:: Cryosurgery*
Neoplastic Cells, Circulating*
Prostatic Neoplasms*/drug therapy
Prostatic Neoplasms*/surgery
Androgen Antagonists/therapeutic use ; Androgens ; Humans ; Male ; Prognosis ; Prostate-Specific Antigen ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Genomic analysis of circulating tumor cells in adenosquamous carcinoma of the prostate: a case report.
Autorzy:: Kitamura J; Department of Urology, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo, 181-8611, Japan.
Taguchi S; Department of Urology, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo, 181-8611, Japan. .
Okegawa T; Department of Urology, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo, 181-8611, Japan.
Honda K; Department of Urology, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo, 181-8611, Japan.
Kii T; Department of Urology, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo, 181-8611, Japan.
Tomida Y; Department of Urology, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo, 181-8611, Japan.
Matsumoto R; Department of Urology, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo, 181-8611, Japan.
Ninomiya N; Department of Urology, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo, 181-8611, Japan.
Masuda K; Department of Urology, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo, 181-8611, Japan.
Nakamura Y; Department of Urology, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo, 181-8611, Japan.
Yamaguchi T; Department of Urology, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo, 181-8611, Japan.
Kinjo M; Department of Urology, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo, 181-8611, Japan.
Tambo M; Department of Urology, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo, 181-8611, Japan.
Isomura A; Department of Pathology, Kyorin University School of Medicine, Tokyo, Japan.
Hayashi A; Department of Pathology, Kyorin University School of Medicine, Tokyo, Japan.
Kamma H; Department of Pathology, Kyorin University School of Medicine, Tokyo, Japan.
Higashihara E; Department of ADPKD Research, Kyorin University School of Medicine, Tokyo, Japan.
Shibahara J; Department of Pathology, Kyorin University School of Medicine, Tokyo, Japan.
Fukuhara H; Department of Urology, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo, 181-8611, Japan.; Pokaż więcej
Źródło:: BMC medical genomics [BMC Med Genomics] 2021 Sep 03; Vol. 14 (1), pp. 217. Date of Electronic Publication: 2021 Sep 03.
Typ publikacji:: Journal Article
MeSH Terms:: Neoplastic Cells, Circulating*

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Modification of Hemodialysis Membranes for Efficient Circulating Tumor Cell Capture for Cancer Therapy.
Autorzy:: Jarvas G; Research Institute of Biomolecular and Chemical Engineering, Faculty of Engineering, University of Pannonia, 8200 Veszprem, Hungary.; CAPTEC Medical Ltd., 1124 Budapest, Hungary.
Szerenyi D; Research Institute of Biomolecular and Chemical Engineering, Faculty of Engineering, University of Pannonia, 8200 Veszprem, Hungary.
Tovari J; Department of Experimental Pharmacology, National Institute of Oncology, 1122 Budapest, Hungary.
Takacs L; Laboratory of Monoclonal Antibody Proteomics, Department of Human Genetics, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Guttman A; Research Institute of Biomolecular and Chemical Engineering, Faculty of Engineering, University of Pannonia, 8200 Veszprem, Hungary.; Pokaż więcej
Źródło:: Molecules (Basel, Switzerland) [Molecules] 2021 Aug 10; Vol. 26 (16). Date of Electronic Publication: 2021 Aug 10.
Typ publikacji:: Journal Article
MeSH Terms:: Renal Dialysis*
Neoplasms/*pathology
Neoplasms/*therapy
Neoplastic Cells, Circulating/*pathology
Flow Cytometry ; Fluorescence ; HCT116 Cells ; Humans ; Membranes ; Polymers/chemistry ; Sulfones/chemistry

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Molecular and Dynamic Evaluation of Proteins Related to Resistance to Neoadjuvant Treatment with Chemoradiotherapy in Circulating Tumor Cells of Patients with Locally Advanced Rectal Cancer.
Autorzy:: Silva VSE; Department of Medical Oncology, A.C.Camargo Cancer Center, São Paulo 01509-900, Brazil.
Abdallah EA; International Research Center, A.C.Camargo Cancer Center, São Paulo 01508-010, Brazil.
Flores BCT; International Research Center, A.C.Camargo Cancer Center, São Paulo 01508-010, Brazil.
Braun AC; International Research Center, A.C.Camargo Cancer Center, São Paulo 01508-010, Brazil.
Costa DJF; International Research Center, A.C.Camargo Cancer Center, São Paulo 01508-010, Brazil.
Ruano APC; International Research Center, A.C.Camargo Cancer Center, São Paulo 01508-010, Brazil.
Gasparini VA; International Research Center, A.C.Camargo Cancer Center, São Paulo 01508-010, Brazil.
Silva MLG; Department of Radiotherapy, A.C.Camargo Cancer Center, São Paulo 01509-900, Brazil.
Mendes GG; Department of Radiology, A.C.Camargo Cancer Center, São Paulo 01509-900, Brazil.
Claro LCL; Department of Pathology, A.C.Camargo Cancer Center, São Paulo 01509-900, Brazil.
Calsavara VF; International Research Center, A.C.Camargo Cancer Center, São Paulo 01508-010, Brazil.
Aguiar Junior S; Department of Pelvic Surgery, A.C.Camargo Cancer Center, São Paulo 01509-900, Brazil.
de Mello CAL; Department of Medical Oncology, A.C.Camargo Cancer Center, São Paulo 01509-900, Brazil.
Chinen LTD; International Research Center, A.C.Camargo Cancer Center, São Paulo 01508-010, Brazil.; National Institute for Science and Technology in Oncogenomics and Therapeutic Innovation, São Paulo 01509-900, Brazil.; Pokaż więcej
Źródło:: Cells [Cells] 2021 Jun 18; Vol. 10 (6). Date of Electronic Publication: 2021 Jun 18.
Typ publikacji:: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms:: Drug Resistance, Neoplasm/*genetics
Neoplastic Cells, Circulating/*metabolism
Neoplastic Cells, Circulating/*pathology
Rectal Neoplasms/*metabolism
Rectal Neoplasms/*pathology
Rectum/*metabolism
Rectum/*pathology
Cell Count ; Chemoradiotherapy/methods ; DNA-Binding Proteins/metabolism ; Disease-Free Survival ; Humans ; Immunohistochemistry/methods ; Molecular Dynamics Simulation ; Neoadjuvant Therapy/methods ; Prognosis ; Prospective Studies ; Rectal Neoplasms/genetics ; Thymidylate Synthase/metabolism

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Integration of circulating tumor cell and neutrophil-lymphocyte ratio to identify high-risk metastatic castration-resistant prostate cancer patients.
Autorzy:: Chong W; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA.
Zhang Z; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA.
Luo R; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA.
Gu J; Department of Epidemiology, MD Anderson Cancer Center, Houston, TX, 77030, USA.
Lin J; Department of Medicine, GW Cancer Center, George Washington University, Washington, DC, 20037, USA.
Wei Q; Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN, 37235, USA.
Li B; Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN, 37235, USA.
Myers R; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA.
Lu-Yao G; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA.
Kelly WK; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA.
Wang C; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA. .
Yang H; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2021 Jun 02; Vol. 21 (1), pp. 655. Date of Electronic Publication: 2021 Jun 02.
Typ publikacji:: Journal Article; Observational Study
MeSH Terms:: Lymphocytes/*immunology
Neoplastic Cells, Circulating/*pathology
Neutrophils/*immunology
Prostatic Neoplasms, Castration-Resistant/*mortality
Aged ; Aged, 80 and over ; Blood Platelets ; Follow-Up Studies ; Humans ; Kaplan-Meier Estimate ; Lymphocyte Count ; Male ; Middle Aged ; Platelet Count ; Prognosis ; Progression-Free Survival ; Prospective Studies ; Prostatic Neoplasms, Castration-Resistant/blood ; Prostatic Neoplasms, Castration-Resistant/diagnosis ; Prostatic Neoplasms, Castration-Resistant/pathology ; Retrospective Studies ; Risk Assessment/statistics & numerical data

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Role of circulating tumor cell detection in differentiating tumor recurrence from treatment necrosis of brain gliomas.
Autorzy:: Gao F; Department of Neurosurgery, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China; Key Laboratory of Endocrine Gland Diseases of Zhejiang Province, China.; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; China National Clinical Research Center for Neurological Diseases, Beijing, China.
Zhao W; General Practice Department, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, Zhejiang, China.
Li M; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; China National Clinical Research Center for Neurological Diseases, Beijing, China.
Ren X; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; China National Clinical Research Center for Neurological Diseases, Beijing, China.
Jiang H; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; China National Clinical Research Center for Neurological Diseases, Beijing, China.
Cui Y; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; China National Clinical Research Center for Neurological Diseases, Beijing, China.
Lin S; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.; China National Clinical Research Center for Neurological Diseases, Beijing, China.; Pokaż więcej
Źródło:: Bioscience trends [Biosci Trends] 2021 May 11; Vol. 15 (2), pp. 107-117. Date of Electronic Publication: 2021 Apr 29.
Typ publikacji:: Journal Article
MeSH Terms:: Brain Neoplasms/*therapy
Glioma/*therapy
Neoplasm Recurrence, Local/*diagnosis
Neoplastic Cells, Circulating/*pathology
Radiation Injuries/*diagnosis
Adult ; Brain/diagnostic imaging ; Brain/pathology ; Brain/radiation effects ; Brain/surgery ; Brain Neoplasms/blood ; Brain Neoplasms/diagnosis ; Brain Neoplasms/pathology ; Chemoradiotherapy, Adjuvant/adverse effects ; Diagnosis, Differential ; Female ; Glioma/blood ; Glioma/diagnosis ; Glioma/pathology ; Humans ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Necrosis/blood ; Necrosis/diagnosis ; Necrosis/pathology ; Neoplasm Recurrence, Local/blood ; Positron-Emission Tomography ; ROC Curve ; Radiation Injuries/blood ; Radiation Injuries/etiology ; Radiation Injuries/pathology ; Retrospective Studies ; Temozolomide/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Highly Correlated Recurrence Prognosis in Patients with Metastatic Colorectal Cancer by Synergistic Consideration of Circulating Tumor Cells/Microemboli and Tumor Markers CEA/CA19-9.
Autorzy:: Chu HY; Department of Engineering and System Science, National Tsing Hua University, Hsinchu 30013, Taiwan.; Molecular Medicine Research Center, Chang Gung University, Taoyuan 33302, Taiwan.
Yang CY; Department Education Research, Taipei City Hospital, Taipei 10341, Taiwan.; Center for General Education, National United University, Miaoli 36003, Taiwan.; General Education Center, University of Taipei, Taipei 110014, Taiwan.
Yeh PH; Department of Engineering and System Science, National Tsing Hua University, Hsinchu 30013, Taiwan.
Hsu CJ; Department of Engineering and System Science, National Tsing Hua University, Hsinchu 30013, Taiwan.
Chang LW; Department of Engineering and System Science, National Tsing Hua University, Hsinchu 30013, Taiwan.
Chan WJ; Department of Engineering and System Science, National Tsing Hua University, Hsinchu 30013, Taiwan.
Lin CP; Institute of Microbiology and Immunology, National Yang-Ming Chiao-Tung University, Taipei 11221, Taiwan.
Lyu YY; Institute of Microbiology and Immunology, National Yang-Ming Chiao-Tung University, Taipei 11221, Taiwan.
Wu WC; Department of Engineering and System Science, National Tsing Hua University, Hsinchu 30013, Taiwan.; Nano Science and Technology Program, Taiwan International Graduate Program, Academia Sinica, Taipei 115, Taiwan.
Lee CW; Department of Engineering and System Science, National Tsing Hua University, Hsinchu 30013, Taiwan.
Wu JK; Department of Engineering and System Science, National Tsing Hua University, Hsinchu 30013, Taiwan.; Biomedical Science and Engineering Center, National Tsing Hua University, No. 101, Sec. 2, Kuang-Fu Rd., Hsinchu 30013, Taiwan.
Jiang JK; Department of Surgery, Division of Colorectal Surgery, Taipei Veterans General Hospital, Taiwan School of Medicine, National Yang-Ming Chiao-Tung University, Taipei 11217, Taiwan.
Tseng FG; Department of Engineering and System Science, National Tsing Hua University, Hsinchu 30013, Taiwan.; Nano Science and Technology Program, Taiwan International Graduate Program, Academia Sinica, Taipei 115, Taiwan.; Department of Engineering and System Science, Frontier Research Center on Fundamental and Applied Sciences of Matters, National Tsing-Hua University, Hsinchu 30013, Taiwan.; Research Center for Applied Sciences, Academia Sinica, No. 128, Sec. 2, Academia Rd., Nankang, Taipei 11529, Taiwan.; Pokaż więcej
Źródło:: Cells [Cells] 2021 May 10; Vol. 10 (5). Date of Electronic Publication: 2021 May 10.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Prognosis*
CA-19-9 Antigen/*biosynthesis
Colorectal Neoplasms/*drug therapy
Colorectal Neoplasms/*pathology
Neoplastic Cells, Circulating/*metabolism
Aged ; Algorithms ; Biomarkers, Tumor/blood ; Carcinoembryonic Antigen/biosynthesis ; Colorectal Neoplasms/diagnosis ; Embolism ; Female ; Humans ; Immunoassay ; Kaplan-Meier Estimate ; Liquid Biopsy ; Lymphatic Metastasis ; Male ; Microscopy, Fluorescence ; Middle Aged ; Neoplasm Metastasis ; Neoplasm Recurrence, Local ; Odds Ratio ; Pattern Recognition, Automated ; Phenotype ; ROC Curve ; Reproducibility of Results

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Usefulness of monitoring circulating tumor cells as a therapeutic biomarker in melanoma with BRAF mutation.
Autorzy:: Kiniwa Y; Department of Dermatology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan.
Nakamura K; Department of Dermatology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan.
Mikoshiba A; Department of Dermatology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan.
Ashida A; Department of Dermatology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan.
Akiyama Y; Life Science Research Laboratory, Tosoh Corporation, Ayase, Kanagawa, Japan.
Morimoto A; Life Science Research Laboratory, Tosoh Corporation, Ayase, Kanagawa, Japan.
Okuyama R; Department of Dermatology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2021 Mar 17; Vol. 21 (1), pp. 287. Date of Electronic Publication: 2021 Mar 17.
Typ publikacji:: Journal Article
MeSH Terms:: Neoplastic Cells, Circulating*
Melanoma/*therapy
Protein Kinase Inhibitors/*therapeutic use
Proto-Oncogene Proteins B-raf/*antagonists & inhibitors
Skin Neoplasms/*therapy
Aged ; Aged, 80 and over ; Chemotherapy, Adjuvant/methods ; Drug Resistance, Neoplasm/genetics ; Feasibility Studies ; Female ; Genetic Heterogeneity ; Humans ; Male ; Melanoma/blood ; Melanoma/diagnosis ; Melanoma/genetics ; Middle Aged ; Molecular Targeted Therapy/methods ; Neoplasm Staging ; Protein Kinase Inhibitors/pharmacology ; Proto-Oncogene Proteins B-raf/genetics ; Skin Neoplasms/blood ; Skin Neoplasms/genetics

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Circulating tumor cell"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język